Fundraising Fox
NanoCellect Biomedical
San Diego, US · Founded 2011 · Delaware corporation · 7 known investors
Find your way into NanoCellect Biomedical
Sign up to find every way you can get introduced to NanoCellect Biomedical
- Your email: who you already know at NanoCellect Biomedical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NanoCellect Biomedical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Developer of microfluidic cell sorting technologies for the biotech industry.
Founders & leadership
NanoCellect Biomedical was founded in 2011 by Jose Morachis.
Board
Investors · 7
How we know: the company's own site · Vertical Venture Partners's portfolio page · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Anzu Partners's portfolio page · funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: FusionX Ventures's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Hemisphere Ventures LLC's portfolio page · Not right? Tell us
How we know: Illumina Ventures's portfolio page · a partner's Signal profile · funding news · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Paladin Capital Group's portfolio page · a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$60.6M disclosed across 5 of 6 rounds · 2015–2023
- Undisclosed amountSeries AFeb 2016Source ↗
▶$28.9MraisedJun 2023 · 32 investors · BiotechnologyRule 506(b)
- Jose MorachisExecutive Officer
- Nicolas BarthelemyDirector
- Chris NearyExecutive Officer, Director
- Paul ConleyDirector
- Jeremy BakerExecutive Officer
- Offering amount
- $38.5M
- Amount sold
- $28.9M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedAug 2021 · 15 investors · BiotechnologyRule 506(b)
- Jeremy BakerExecutive Officer
- Jack BallDirector
- Paul ConleyDirector
- Chris NearyExecutive Officer, Director
- Alexis JiDirector
- Nicolas BarthelemyDirector
- Jose MorachisExecutive Officer, Director
- Kenneth HoodDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedDec 2017 · 11 investors · BiotechnologyRule 506(b)
- Jack BallDirector
- Nate HeintzmanExecutive Officer
- Kenneth HoodDirector
- Jose MorachisExecutive Officer, Director
- William AlaynickExecutive Officer, Director
- Alexis JiDirector
- Offering amount
- $7.5M
- Amount sold
- $7.4M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJul 2017 · 4 investors · BiotechnologyRule 506(b)
- Kenneth HoodDirector
- William AlaynickExecutive Officer, Director
- Nate HeintzmanExecutive Officer, Director
- Jose MorachisExecutive Officer, Director
- Jack BallDirector
- Offering amount
- $3M
- Amount sold
- $2.5M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJan 2016 · 3 investors · BiotechnologyRule 506(b)
- Kenneth HoodDirector
- Jose MorachisExecutive Officer, Director
- Nate HeintzmanExecutive Officer, Director
- William AlaynickExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through NanoCellect Biomedical went on to found or lead other companies.
Related companies · 3
Companies working in the same space as NanoCellect Biomedical.
Non-dilutive funding · 16 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $214K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $976.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $691.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2012 | $972.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $199.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $698K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $289.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $198.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $166.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NanoCellect Biomedical do?
- Developer of microfluidic cell sorting technologies for the biotech industry.
- Who founded NanoCellect Biomedical?
- NanoCellect Biomedical was founded by Jose Morachis in 2011.
- Who are NanoCellect Biomedical's investors?
- NanoCellect Biomedical's investors include Vertical Venture Partners, Warburg Pincus, Anzu Partners, FusionX Ventures, Hemisphere Ventures LLC, Illumina Ventures, Paladin Capital Group.
- How much funding has NanoCellect Biomedical raised?
- NanoCellect Biomedical has disclosed $60.6M raised across 5 of its 6 known rounds.
- Where is NanoCellect Biomedical headquartered?
- NanoCellect Biomedical is headquartered in San Diego, US.